Disease: Diphosphoglycerate mutase deficiency of erythrocyte
- 2,3-diphosphoglycerate metabolism and 2,3-diphosphoglycerate mutase deficiency in erythrocytes
- Acquired erythroenzymopathies in blood disorders: study of 200 cases
- Action of growth hormone on erythropoiesis: changes in red blood cell enzyme activities in growth-retarded patients with and without growth hormone deficiency
- Advances in hereditary red cell enzyme abnormalities
- Advances in hereditary red cell enzyme anomalies
- Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia
- Biphosphoglycerate Mutase: A Novel Therapeutic Target for Malaria?
- Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia
- Clinical consequences of enzyme deficiencies in the erythrocyte
- Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency
- Congenital non-spherocytic hemolytic anemia by 2,3-diphosphoglycerate mutase deficiency of the erythrocytes in early infancy
- Enzyme deficiencies in glycolysis and nucleotide metabolism of red blood cells in nonspherocytic hemolytic anemia (author's transl)
- Enzyme deficiencies of blood cells in bone marrow insufficiency (author's transl
- Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming
- Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model
- Erythrocyte enzyme defects and their clinical significance (author's transl)
- Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency
- Familial diphosphoglycerate mutase deficiency: hematological and biochemical study
- Glycerated hemoglobin alpha 2 beta 2(82) (EF6) N-epsilon-glyceryllysine: a new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency
- Glycerated hemoglobin, alpha 2A beta 2(82) (EF6) N epsilon-glyceryllysine. A new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency
- Hemolytic anemias and erythrocyte enzymopathies
- Hemolytic anemias due to erythrocyte enzyme deficiencies
- Hereditary disorders of red cell enzymes in the Embden-Meyerhof pathway
- Hereditary hemolytic anemia due to erythrocyte enzyme deficiency (author's transl)
- Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes
- Metabolic manipulation of key glycolytic enzymes: a novel proposal for the maintenance of red cell 2,3-DPG and ATP levels during storage
- Metabolic pathway analysis of enzyme-deficient human red blood cells
- Metabolism in haemolytic states
- Molecular basis of red cell enzymopathies associated with hereditary nonspherocytic hemolytic anemia
- New advances in the diagnosis of erythro-enzymopathies
- Red cell enzymopathies in the newborn. II. Inherited deficiencies of red cell enzymes
- Red cell enzymopathies of the glycolytic pathway
- Red cell glycolytic enzyme disorders caused by mutations: an update
- Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis
- The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes
- The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism
- Transfusion requirements of patients with enzyme deficient red blood cells